Regulatory Approval, Implementation, and Brief Assessment of a Pharmacist- and Pharmacy Trainee-Administered Penicillin Allergy Assessment and Skin Testing Program

Author(s):  
Nicole C. Griffith ◽  
Julie Ann Justo ◽  
Hana R. Winders ◽  
Majdi N. Al-Hasan ◽  
Krutika N. Mediwala ◽  
...  
2020 ◽  
Vol 145 (2) ◽  
pp. AB54
Author(s):  
Rajan Ravikumar ◽  
Sherry Zhou ◽  
Gregory Eschenauer ◽  
David Bozaan ◽  
Elizabeth Spranger ◽  
...  

2017 ◽  
Vol 4 (suppl_1) ◽  
pp. S266-S267 ◽  
Author(s):  
Christopher Kovacs ◽  
Vasilios Athans ◽  
David Lang ◽  
Ronald Sobecks ◽  
Lisa Rybicki ◽  
...  

2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S90-S90
Author(s):  
Kendall J Tucker ◽  
YoungYoon Ham ◽  
Haley K Holmer ◽  
Caitlin M McCracken ◽  
Ellie Sukerman ◽  
...  

Abstract Background Beta-lactam (BL) antibiotics are first-line agents for most patients receiving antimicrobial prophylaxis in surgical procedures. Despite evidence showing low cross-reactivity between classes of BLs, patients with allergies commonly receive vancomycin as an alternative to avoid allergic reaction. The objective of this study was to identify potentially inappropriate use of vancomycin surgical prophylaxis among patients with reported BL allergies. Methods Adult patients (≥18 years) receiving vancomycin for surgical prophylaxis with a reported penicillin and/or cephalosporin allergy at our institution between August 2017 to July 2018 were retrospectively evaluated for potential eligibility for penicillin allergy testing and/or receipt of standard prophylaxis. Surgery type and allergy history were extracted from the electronic medical record. Per our institution’s penicillin-testing protocol, patients with IgE-mediated reactions < 10 years ago were eligible for penicillin skin testing (PST), mild reactions or IgE-mediated reaction > 10 years ago were eligible for direct oral amoxicillin challenge, and severe non-IgE mediated allergies were ineligible for penicillin allergy evaluation or BL prophylaxis. Results Among 830 patients who received vancomycin for surgical prophylaxis, 196 reported BL allergy and were included in the analysis (155 with penicillin allergy alone; 21 with cephalosporin allergy; 20 with both cephalosporin and penicillin allergy). Approximately 40% of surgeries were orthopedic. Six patients were ineligible for BL prophylaxis. Per institutional protocol, 73 of 155 patients (48%) may have qualified for PST; 81 of 155 (52%) patients may have received a direct oral amoxicillin challenge. Only 3 of 22 patients with history of methicillin-resistant Staphylococcus aureus appropriately received additional prophylaxis with vancomycin and a BL. Conclusion Patients with BL allergies often qualify for receipt of a first-line BL antibiotic. An opportunity exists for improved BL allergy assessment as an antimicrobial stewardship intervention. Future studies should evaluate outcomes associated with BL allergy evaluation and delabeling in patients receiving surgical prophylaxis. Disclosures All Authors: No reported disclosures


2007 ◽  
Vol 27 (4) ◽  
pp. 542-545 ◽  
Author(s):  
Jeremy A Schafer ◽  
Noe Mateo ◽  
Garry L Parlier ◽  
John C Rotschafer

1981 ◽  
Vol 68 (3) ◽  
pp. 169-170 ◽  
Author(s):  
Richard G. Van Dellen

2017 ◽  
Vol 119 (3) ◽  
pp. 258-261 ◽  
Author(s):  
Bob Geng ◽  
Jacqueline J. Eastman ◽  
Karen Mori ◽  
Melinda Braskett ◽  
Marc A. Riedl

1986 ◽  
Vol 151 (7) ◽  
pp. 395-399
Author(s):  
Dean T. Noritake ◽  
Michael A. Sue ◽  
William B. Klaustermeyer

Sign in / Sign up

Export Citation Format

Share Document